Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

In response to growing public concern, Character.ai is banning users under 18 from open-ended chatbot conversations. The company will add age verification and create an AI Safety Lab as well. The move ...

Content warning: this story includes discussion of self-harm and suicide. If you are in crisis, please call, text or chat with the Suicide and Crisis Lifeline at 988, or contact the Crisis Text Line ...

Character.ai will ban children under age 18 from having “open-ended chats” with its chatbots, the company said in a blog post on Wednesday, a change that comes as the AI company faces bipartisan ...

The start-up, which creates A.I. companions, faces lawsuits from families who have accused Character.AI’s chatbots of leading teenagers to kill themselves. By Natallie Rocha and Kashmir Hill Natallie ...

EDITOR’S NOTE: This story contains discussion of suicide. Help is available if you or someone you know is struggling with suicidal thoughts or mental health matters. In the US: Call or text 988, the ...

Abstract: The short packet transmission (SPT) has gained much attention in recent years. In SPT, the most significant characteristic is that the finite blocklength code (FBC) is adopted. With FBC, the ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...